#JPM2026 Post-Event Report

The JP Morgan Healthcare conference is a well-established bellwether for the biopharma market. It sets the tone – and expectations – for the year ahead. What did JP Morgan 2026 bring? Find out in Evaluate’s post-event round up which brings together the highlights, the trends and the sentiment about a year that many hope to be the turnaround that pharma and biotech needs.

Our experts have scrutinized the presentations to bring you detailed insights about the event and what it means for biotechs, pharma companies and life sciences investors.

Share:

Download today








#JPM2026 Post-Event Report

Your definitive guide to the biggest announcements and takeaways from this year’s most influential healthcare summit. See our roundup of mega cap, large cap, mid cap, small cap, and micro cap pharmaceutical companies.

Our experts have analyzed the trends, partnerships, and key presentations from the conference, providing insights you won’t find anywhere else.

Download the report now and stay ahead with unparalleled coverage and insights.

 

Upcoming Webinar

World Preview 2026

Tuesday 16th June 2026 | 3pm BST

By 2032, the global pharmaceutical market is forecast to reach almost $1.9tn. Inside the innovations, dealmaking, and portfolio strategies transforming the global biopharma pipeline.

Related Content